抄録
Non-occlusive mesenteric ischemia (NOMI) is described as discontinuous or segmental intestinal ischemia and/or necrosis even with patent mesenteric vessels. NOMI has no specific symptoms during the early onset stage, so making an accurate diagnosis is very difficult. Hence, patients with NOMI have a high mortality rate. Therefore, early diagnosis and treatment are very important. The usefulness of intra-arterial vasodilator infusion therapy as an endovascular treatment has already been reported, but its future role is currently unclear. Herein, we introduce the current state of NOMI management and the practice of endovascular therapy.
